Literature DB >> 30049259

Trends in HIV prevalence among people injecting drugs, men having sex with men, and female sex workers in Ukraine.

Kostyantyn Dumchev1, Yana Sazonova2, Tetiana Salyuk2, Olga Varetska2.   

Abstract

Once recognized as the most severe in Europe, the HIV epidemic in Ukraine is concentrated among people who inject drugs, men who have sex with men, and female sex workers. Integrated biobehavioral surveys, as a part of the second generation surveillance, are used to monitor HIV infection trends in key populations since 2002. The present paper is focused on the analysis of HIV prevalence trends in four nationally representative rounds of integrated biobehavioral surveys from 2008/9, 2011, 2013, and 2015 in people who inject drugs, men who have sex with men, and female sex workers. Between 2008/9 and 2015, the HIV prevalence has decreased significantly in people who inject drugs (24.2 to 22.0%) and female sex workers (13.6 to 6.3%), while the change in men who have sex with men was not significant (8.5 to 7.8%). There was a significant increase in people who inject drugs and men who have sex with men between 2013 and 2015. In subgroups younger than 25 years, prevalence increased more than twofold in men who have sex with men (1.9 to 4.3%), with no changes in people who inject drugs and female sex workers. The observed decline in prevalence, especially in young subgroups, may result from the effect of extensive prevention efforts on drug injection-related transmission. Recent increase in young men who have sex with men may be a sign of a new wave of the epidemic in this group.

Entities:  

Keywords:  Europe; HIV; epidemiology; homosexual; sex workers

Mesh:

Year:  2018        PMID: 30049259     DOI: 10.1177/0956462418784096

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  7 in total

1.  Divergent estimates of HIV incidence among people who inject drugs in Ukraine.

Authors:  Olga Morozova; Robert E Booth; Sergii Dvoriak; Kostyantyn Dumchev; Yana Sazonova; Tetiana Saliuk; Forrest W Crawford
Journal:  Int J Drug Policy       Date:  2019-08-10

2.  Operationalizing the HIV prevention cascade for PWID using the integrated bio-behavioural survey data from Ukraine.

Authors:  Kostyantyn Dumchev; Yana Sazonova; Pavlo Smyrnov; Olga Cheshun; Oksana Pashchuk; Tetiana Saliuk; Olga Varetska
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

3.  Anxiety symptoms and felt stigma among young people living with perinatally or behaviourally-acquired HIV in Ukraine: A cross-sectional survey.

Authors:  Marion Durteste; Galyna Kyselyova; Alla Volokha; Ali Judd; Claire Thorne; Mario Cortina-Borja; Ruslan Malyuta; Violeta Martsynovska; Nataliya Nizova; Heather Bailey
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

4.  The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.

Authors:  David Otiashvili; Tamar Mgebrishvili; Ada Beselia; Irina Vardanashvili; Kostyantyn Dumchev; Tetiana Kiriazova; Irma Kirtadze
Journal:  Harm Reduct J       Date:  2022-03-09

5.  A qualitative exploration of daily path and daily routine among people in Ukraine who inject drugs to understand associated harms.

Authors:  Jill Owczarzak; Jessie Chien; Karin Tobin; Alyona Mazhnaya; Olena Chernova; Tetiana Kiriazova
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-05-07

6.  Locally adaptive Bayesian birth-death model successfully detects slow and rapid rate shifts.

Authors:  Andrew F Magee; Sebastian Höhna; Tetyana I Vasylyeva; Adam D Leaché; Vladimir N Minin
Journal:  PLoS Comput Biol       Date:  2020-10-28       Impact factor: 4.475

7.  Is contact between men who have sex with men and non-governmental organizations providing harm reduction associated with improved HIV outcomes?

Authors:  A Trickey; J Stone; N Semchuk; T Saliuk; Y Sazonova; O Varetska; A G Lim; J G Walker; P Vickerman
Journal:  HIV Med       Date:  2020-11-12       Impact factor: 3.180

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.